Sofinnova Partners key facts
- Sofinnova Partners is a venture capital firm based in Paris, France with 58 tracked portfolio companies.
- Notable positions include DNA Script, Hemab Therapeutics Holdings, Galvanize Therapeutics.
- PrivateMarketView records 1 deal participation by Sofinnova Partners.
About Sofinnova Partners
Founded in 1972, Sofinnova Partners is a venture capital firm based in Paris, France. The firm prefers to invest in companies operating in the life sciences sector and primarily focuses on investing in the healthcare and sustainability sectors.
Investment activity
Sofinnova Partners joined 1 recorded round in the last two years. Sofinnova Partners is recorded as lead on 1 of them. 1 round landed in the last 90 days. Most recently: HighLife (later-stage round, Sep 2026).
Sofinnova Partners portfolio at a glance
58 portfolio companies are on record for Sofinnova Partners, including DNA Script, Hemab Therapeutics Holdings and Galvanize Therapeutics.
39 of the 58 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
- ·The top 10 names in the book — of 58 recorded positions
- ·Watchlist + alerts for Sofinnova Partners's activity
Portfolio
58 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| DNA Script | Biotechnology | ▮ | ▮ | ▮ |
| Hemab Therapeutics Holdings | Drug Discovery | ▮ | ▮ | ▮ |
| Galvanize Therapeutics | Therapeutic Devices | ▮ | ▮ | ▮ |
+ 55 more companies · all 58, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Sofinnova Partners recent deals
1 recordedMembership and data by Private Market View
Frequently asked about Sofinnova Partners
- What companies does Sofinnova Partners invest in?
- Sofinnova Partners has 58 recorded portfolio companies, including DNA Script, Hemab Therapeutics Holdings, Galvanize Therapeutics.
- What is Sofinnova Partners's AUM?
- Sofinnova Partners manages approximately $4.6B in assets.